Connect with us

Press Releases

Inspecs Announces Final Results for the Year

2019 was a milestone year for Inspecs, CEO says.

mm

Published

on

(PRESS RELEASE) Inspecs Group plc, a designer, manufacturer and distributor of eyewear frames to global retail chains, announces its Final Results for the year ended 31 December 2019.

Group Highlights

  • Group revenue increased 6.9% to $61.25m (2018: $57.30m)
  • Underlying EBITDA increased 9.4% to $12.99m (2018: $11.87m)
  • Profit Before Tax increased 102.4% to $7.35m (2018: $3.63m)
  • Basic EPS increased 84.0% to $16.38c (2018: $8.90c)
  • Diluted EPS increased 81.8% to $14.80c (2018: $8.14c)
  • Manufactured 4.55m eyewear frames, up 19.7% (2018: 3.80m)
  • Expansion of Vietnam factory from 4,300 square meters to 8,800 square meters

Post Period End

  • Successful flotation on the London Stock Exchange’s Alternative Investment Market (AIM) in February 2020
  • Appointed Angela Farrugia to the Board as a Non-Executive Director on 12 May 2020
  • Winner of the Queen’s Award for Enterprise: International Trade for Outstanding Short-Term Growth in overseas sales

Robin Totterman, CEO of Inspecs said:

“This was a milestone year for Inspecs as we successfully listed on AIM and continued to make significant progress with our growth strategy, culminating in a strong set of results.

“Despite this pleasing performance, in recent months our focus as a management team and across the business has of course been squarely on managing the impact of COVID-19 on our operations. We have taken a number of actions to reduce costs, preserve cash and protect our balance sheet and we are confident that we have a robust liquidity position which will see us through the challenges ahead.

“Our number one priority at all times has been the health, safety and wellbeing of our brilliant people and I am proud of the way our core values have shone through. Nowhere was this better demonstrated than by the speed at which we diverted production to supply safety eyewear to frontline medical professionals in the NHS.

“Over the long term, the structural growth drivers in the $131 billion global eyewear market remain unchanged and people will still require vision correction. Our resilient vertically integrated business model and manufacturing capabilities combined with the innovation of our design teams and the strength of our customer relationships, leaves us well positioned to benefit from the recovery as a leaner, more efficient business.”

Advertisement

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Most Popular